Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease.
Open accessThe DOI matches its Crossref record.
Abstract
Changes in the structure of the proteoglycan aggrecan (PG) of articular cartilage were determined immunochemically by RIA and gel chromatography and related to cartilage degeneration documented histologically by the Mankin grading system. Monoclonal antibodies to glycosaminoglycan epitopes were used. In all cartilages, three chondroitin sulfate (CS)-rich populations of large size were observed in addition to a smaller keratan sulfate (KS)-rich population. In grades 7-13 OA cartilages (phase II), molecules were significantly larger than the equivalent molecules of grades 2-6 (phase I). CS chain lengths remained unchanged. In most OA cartilages, a CS epitope 846 was elevated in content, this being most marked in phase II (mean: fivefold). Loss of uronic acid, KS, and hyaluronic acid were only pronounced in phase II OA because of variations in normal contents. Aggregation of PG was unchanged (50-60%) or reduced in OA cartilages, but molecules bearing epitope 846 exhibited almost complete aggregation in normal cartilages. This study provides evidence for the capacity of OA cartilage to synthesize new aggrecan molecules to replace those damaged and lost by disease-related changes. It also defines two phases of PG change in OA: an early predominantly degenerate phase I followed by a net reparative phase II accompanied by net loss of these molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antoniou, J., Steffen, T., Nelson, F., Winterbottom, N., Hollander, A. P., Poole, R. A., Aebi, M., & Alini, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118884 · Cited by 1,045
Hollander, A. P., Heathfield, T. F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C., & Poole, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117156 · Cited by 611
Self-citationKobayashi, M., Squires, G. R., Mousa, A., Tanzer, M., Zukor, D. J., Antoniou, J., Feige, U., & Poole, A. R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20776 · Cited by 497
Self-citationRoos, E. M., & Dahlberg, L. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21415 · Cited by 476
Goa, K. L., & Benfield, P. (1994) · Drugs · doi:10.2165/00003495-199447030-00009 · Cited by 421
Garnero, P., Rousseau, J.-C., & Delmas, P. D. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<953::aid-anr1>3.0.co;2-q · Cited by 409
Osteoarthritis: An Overview of the Disease and Its Treatment Strategies
Sarzi-Puttini, P., Cimmino, M. A., Scarpa, R., Caporali, R., Parazzini, F., Zaninelli, A., Atzeni, F., & Canesi, B. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.01.013 · Cited by 400
Cartilage proteoglycans: Structure and potential functions
Roughley, P. J., & Lee, E. R. (1994) · Microscopy Research and Technique · doi:10.1002/jemt.1070280505 · Cited by 348
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
Kraus, V. B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., et al. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.08.019 · Cited by 328
Self-citationEvidence for altered synthesis of type II collagen in patients with osteoarthritis.
Nelson, F., Dahlberg, L., Laverty, S., Reiner, A., Pidoux, I., Ionescu, M., Fraser, G. L., Brooks, E., Tanzer, M., Rosenberg, L. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4853 · Cited by 298
Self-citationChanges in joint cartilage aggrecan after knee injury and in osteoarthritis
Lohmander, L. S., Ionescu, M., Jugessur, H., & Poole, A. R. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:3<534::aid-anr19>3.0.co;2-j · Cited by 264
Self-citationMånsson, B., Carey, D., Alini, M., Ionescu, M., Rosenberg, L. C., Poole, A. R., Heinegård, D., & Saxne, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117753 · Cited by 248
Self-citationBiological markers in osteoarthritis
Rousseau, J.-C., & Delmas, P. D. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0508 · Cited by 237
“Synovial fluid levels of epitope 846 increase in patients suffering from OA [30].”
BackgroundMouw, J. K., Case, N. D., Guldberg, R. E., Plaas, A. H. K., & Levenston, M. E. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.04.020 · Cited by 158
Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis
Matyas, J. R., Atley, L., Ionescu, M., Eyre, D. R., & Poole, A. R. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20027 · Cited by 158
“Aggrecan 846 epitope is present on intact aggrecan molecules (the epitope is associated with chondroitin sulfate chains near the G3 domain in healthy and OA cartilage [20]).”
BackgroundSelf-citation
Metadata
- Authors
- Rizkalla, G., Reiner, A., Bogoch, E., & Poole, A. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-12-01
- Volume
- 90
- Issue
- 6
- Pages
- 2268-2277
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2007734100
- Cited by
- 250
- References
- 0
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.